Bioinformatics analysis for Taohe Chengqi Decoction in treating diabetic kidney disease and cutaneous pruritus based on the theory of "same treatment for different diseases"

基于“同治不同病”理论的桃和承气汤治疗糖尿病肾病和皮肤瘙痒的生物信息学分析

阅读:2

Abstract

Taohe Chengqi Decoction (THCQD) is a traditional Chinese prescription. Clinical trials have confirmed that THCQD can be used to treat cutaneous pruritus (CP), such as chronic urticaria, by draining down stagnant heat, and meta-analysis has found that in diabetic kidney disease (DKD), it can further improve the efficiency of Western medical treatment, reduce the total amount of 24 hours urinary protein, blood creatinine, and urinary albumin excretion rate, and improve the quality of life of patients. However, the exact pharmacological mechanism by THCQD improves DKD and CP remain unclear due to the complexity of its ingredients. We used network pharmacology approaches, including multi-database search, protein-protein interaction (PPI) network construction, gene ontology enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway analysis and molecular docking to elaborate the active components, signaling pathways and potential mechanisms of THCQD in the treatment of DKD and CP. 114 active ingredients and 87 intersection targets of THCQD and diseases have been found through integrated network pharmacology. And by combining the data, we found the top 5 active ingredients, including beta-sitosterol, 7,2',4'-trihydroxy-5-methoxy-3-arylcoumarin, sitosterol, kaemp ferol and naringenin. Through PPI analysis, TNF, ALB, IL1B, AKT1 and TP53 were identified as the key therapeutic targets. In addition, the underlying effect of the pathways in cancer, AGE-RAGE signaling pathway in diabetic complications, PI3K-Akt signaling pathway, MAPK signaling pathway and TNF signaling pathway are also suggested in the treatment. By validation of molecular docking, finding that the central therapeutic targets have good affinities with the main compounds of THCQD. This study successfully predicts the active compounds, potential targets, and signaling pathways of THCQD in the treatment of DKD and CP. These findings provided an important scientific basis for further research of the mechanism of THCQD in the treatment of DKD and CP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。